Professional Summary
Specializing In
Practice Locations
Patient Ratings
Referring Physicians
Professional Summary
Education & Certifications
- Medical Education: Vanderbilt University School of Medicine (2010) TN
- Residency: University of Washington Dept of Radiation Oncology (2015) WA
- Board Certification: American Board of Radiology, Radiation Oncology (2016)
- Internship: Johns Hopkins Hospital Internal Medicine Residency (2011) MD
- AB with honors, Harvard College, Physics (2005)
Honors & Awards
- ESMO Congress Merit Award, European Society for Medical Oncology (2018)
- Henry S. Kaplan Memorial Prize for Teaching, Stanford Radiation Oncology Residency Program (2022)
- HIMSS Davies Award of Excellence (project lead), Healthcare Information and Management Systems Society (2023)
Memberships
- Member, Annual Meeting Education Committee, American Society for Radiation Oncology (2019 - 2023)
- Member, Head and Neck Cancer General Committee, NRG Oncology (2022 - Present)
Administrative Appointments
- Chair, Data and Safety Monitoring Committee, Stanford Cancer Institute (2020 - Present)
- Member, Data and Safety Monitoring Committee, Stanford Cancer Institute (2018 - Present)
Publications
-
Chalcone isomerase family and fold: No longer unique to plants
Gensheimer, M., & Mushegian, A. (2004). Chalcone isomerase family and fold: No longer unique to plants. PROTEIN SCIENCE, 13(2), 540–544. -
Administration of oxaliplatin to a pregnant woman with rectal cancer
Gensheimer, M., Jones, C. A., Graves, C. R., Merchant, N. B., & Lockhart, A. C. (2009). Administration of oxaliplatin to a pregnant woman with rectal cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 63(2), 371–373. -
IN VIVO PROTON BEAM RANGE VERIFICATION USING SPINE MRI CHANGES
Gensheimer, M. F., Yock, T. I., Liebsch, N. J., Sharp, G. C., Paganetti, H., Madan, N., … Bortfeld, T. (2010). IN VIVO PROTON BEAM RANGE VERIFICATION USING SPINE MRI CHANGES. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(1), 268–275. -
Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective.
Bowen, S. R., Nyflot, M. J., Gensheimer, M., Hendrickson, K. R. G., Kinahan, P. E., Sandison, G. A., & Patel, S. A. (2012). Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective. Clinical and Translational Medicine, 1(1), 18-? -
Neutron Radiotherapy for Adenoid Cystic Carcinoma of the Lacrimal Gland
Gensheimer, M. F., Rainey, D., Douglas, J. G., Liao, J. J., Laramore, G. E., Jian-Amadi, A., … Parvathaneni, U. (2013). Neutron Radiotherapy for Adenoid Cystic Carcinoma of the Lacrimal Gland. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 29(4), 256–60. -
Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes
Gensheimer, M. F., Liao, J. J., Garden, A. S., Laramore, G. E., & Parvathaneni, U. (2014). Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. RADIATION ONCOLOGY, 9. -
Assessing the scale of tumor heterogeneity by complete hierarchical segmentation of MRI
Gensheimer, M. F., Hawkins, D. S., Ermoian, R. P., & Trister, A. D. (2015). Assessing the scale of tumor heterogeneity by complete hierarchical segmentation of MRI. PHYSICS IN MEDICINE AND BIOLOGY, 60(3), 977–93. -
Simple tool for prediction of parotid gland sparing in intensity-Modulated radiation therapy
Gensheimer, M. F., Hummel-Kramer, S. M., Cain, D., & Quang, T. S. (2015). Simple tool for prediction of parotid gland sparing in intensity-Modulated radiation therapy. MEDICAL DOSIMETRY, 40(3), 232–34. -
Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
Wu, J., Gensheimer, M. F., Dong, X., Rubin, D. L., Napel, S., Diehn, M., … Li, R. (2016). Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. International Journal of Radiation Oncology, Biology, Physics, 95(5), 1504–12. -
The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most?
Cho, E., Rubinstein, L., Stevenson, P., Gooley, T., Philips, M., Halasz, L. M., … Gadi, V. K. (2015). The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most? BREAST CANCER RESEARCH AND TREATMENT, 149(3), 743–49. -
Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
Kapeles, M., Gensheimer, M. F., Mart, D. A., Sottero, T. L., Kusano, A. S., Truong, A., … Patel, S. A. (2015). Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review. American Journal of Clinical Oncology, -? -
Mentorship Programs in Radiation Oncology Residency Training Programs: A Critical Unmet Need
Dhami, G., Gao, W., Gensheimer, M. F., Trister, A. D., Kane, G., & Zeng, J. (2016). Mentorship Programs in Radiation Oncology Residency Training Programs: A Critical Unmet Need. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 94(1), 27–30. -
Influence of planning time and treatment complexity on radiation therapy errors.
Gensheimer, M. F., Zeng, J., Carlson, J., Spady, P., Jordan, L., Kane, G., & Ford, E. C. (2016). Influence of planning time and treatment complexity on radiation therapy errors. Practical Radiation Oncology, 6(3), 187–93. -
Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
Chaudhuri, A. A., Binkley, M. S., Rigdon, J., Carter, J. N., Aggarwal, S., Dudley, S. A., … Guo, H. H. (2016). Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). Radiotherapy and Oncology , 119(3), 454–60. -
Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.
Pollom, E. L., Qian, Y., Durkee, B. Y., von Eyben, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2016). Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer. Clinical Lung Cancer, 17(6), 588–94. -
Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.
Binkley, M. S., King, M. T., Shrager, J. B., Bush, K., Chaudhuri, A. A., Popat, R., … Loo, B. W. (2017). Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiotherapy and Oncology , 123(2), 270–75. -
Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique
Gensheimer, M. F., Nyflot, M., Laramore, G. E., Liao, J. J., & Parvathaneni, U. (2016). Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique. RADIATION ONCOLOGY, 11. -
Optimal Radiation Therapy for Small Cell Lung Cancer.
Gensheimer, M. F., & Loo, B. W. (2017). Optimal Radiation Therapy for Small Cell Lung Cancer. Current Treatment Options in Oncology, 18(4), 21-? -
Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors.
Qian, Y., Zhu, H., Pollom, E. L., Durkee, B. Y., Chaudhuri, A. A., Gensheimer, M. F., … Loo, B. W. (2017). Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors. Practical Radiation Oncology. -
SU-D-207B-05: Robust Intra-Tumor Partitioning to Identify High-Risk Subregions for Prognosis in Lung Cancer.
Wu, J., Gensheimer, M., Dong, X., Rubin, D., Napel, S., Diehn, M., … Li, R. (2016). SU-D-207B-05: Robust Intra-Tumor Partitioning to Identify High-Risk Subregions for Prognosis in Lung Cancer. Medical Physics, 43(6), 3349-? -
Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC.
Lee, J., Cui, Y., Sun, X., Li, B., Wu, J., Li, D., … Li, R. (2017). Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC. European Radiology. -
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling.
Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., … Diehn, M. (2017). Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery. -
Chest wall dose reduction using noncoplanar volumetric modulated arc radiation therapy for lung stereotactic ablative radiation therapy.
Yu, A. S., Maxim, P. G., Loo, B. W., & Gensheimer, M. F. (2017). Chest wall dose reduction using noncoplanar volumetric modulated arc radiation therapy for lung stereotactic ablative radiation therapy. Practical Radiation Oncology. -
A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
Lee, J., Li, B., Cui, Y., Sun, X., Wu, J., Zhu, H., … Li, R. (2018). A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. -
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
Chin, A. L., Kumar, K. A., Guo, H. H., Maxim, P. G., Wakelee, H., Neal, J. W., … Gensheimer, M. F. (2018). Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer. Clinical Lung Cancer. -
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer
Gensheimer, M. F., Hong, J. C., Chang-Halpenny, C., Zhu, H., Eclov, N. C. W., To, J., … Loo, B. W. (2017). Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. RADIOTHERAPY AND ONCOLOGY, 125(2), 338–43. -
Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging
Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., … Diehn, M. (2017). Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 98(2), E4. -
Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives.
Banerjee, I., Gensheimer, M. F., Wood, D. J., Henry, S., Aggarwal, S., Chang, D. T., & Rubin, D. L. (2018). Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives. Scientific Reports, 8(1), 10037. -
Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry, M. F., Canchola, A. J., Gensheimer, M. F., Gomez, S. L., & Cheng, I. (2018). Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis. Clinical Lung Cancer, 19(5), e745–e758. -
Practical workflow for rapid prototyping of radiation therapy positioning devices
Gensheimer, M. F., Bush, K., Juang, T., Herzberg, B., Villegas, M., Maxim, P. G., … Loo, B. W. (2017). Practical workflow for rapid prototyping of radiation therapy positioning devices. PRACTICAL RADIATION ONCOLOGY, 7(6), 442–45. -
Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Tumors Greater Than 5 cm
Anderson, E. M., Sharma, A., Westover, K. D., Timmerman, R., von Eyben, R., Gensheimer, M. F., … Shultz, D. B. (2017). Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Tumors Greater Than 5 cm. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC. -
Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data.
Gensheimer, M. F., Henry, A. S., Wood, D. J., Hastie, T. J., Aggarwal, S., Dudley, S. A., … Chang, D. T. (2018). Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data. Journal of the National Cancer Institute. -
Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice?
Gensheimer, M. F., & Le, Q.-T. (2018). Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice? Oral Oncology, 86, 19–24. -
Impact of Accuracy of Survival Predictions on Quality of End-of-Life Care Among Patients With Metastatic Cancer Who Receive Radiation Therapy.
Sborov, K., Giaretta, S., Koong, A., Aggarwal, S., Aslakson, R., Gensheimer, M. F., … Pollom, E. L. (2019). Impact of Accuracy of Survival Predictions on Quality of End-of-Life Care Among Patients With Metastatic Cancer Who Receive Radiation Therapy. Journal of Oncology Practice, JOP1800516. -
A scalable discrete-time survival model for neural networks.
Gensheimer, M. F., & Narasimhan, B. (2019). A scalable discrete-time survival model for neural networks. PeerJ, 7, e6257. -
Sinoatrial node dysfunction after stereotactic ablative radiation therapy in the chest
Qian, Y., Dudley, S. A., Kumar, K., Chaudhuri, A., Chin, A., Harris, J. P., … Loo, B. W. (2017). Sinoatrial node dysfunction after stereotactic ablative radiation therapy in the chest. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases.
Koenig, J. L., Shi, S., Sborov, K., Gensheimer, M. F., Li, G., Nagpal, S., … Pollom, E. L. (2019). Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases. World Neurosurgery. -
Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy.
Prionas, N. D., von Eyben, R., Yi, E., Aggarwal, S., Shaffer, J., Bazan, J., … Loo, B. W. (2019). Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. Advances in Radiation Oncology, 4(2), 429–37. -
In Regard to Valdes et al.
Gensheimer, M. F., & Trister, A. D. (2018). In Regard to Valdes et al. International Journal of Radiation Oncology, Biology, Physics, 102(5), 1593–1594. -
Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives
Banerjee, I., Gensheimer, M. F., Wood, D. J., Henry, S., Aggarwal, S., Chang, D. T., & Rubin, D. L. (2018). Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives. SCIENTIFIC REPORTS, 8. -
A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer
Lee, J., Li, B., Cui, Y., Sun, X., Wu, J., Zhu, H., … Li, R. (2018). A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(4), 1098–1106. -
Chest wall dose reduction using noncoplanar volumetric modulated arc radiation therapy for lung stereotactic ablative radiation therapy
Yu, A. S., Maxim, P. G., Loo, B. W., & Gensheimer, M. F. (2018). Chest wall dose reduction using noncoplanar volumetric modulated arc radiation therapy for lung stereotactic ablative radiation therapy. PRACTICAL RADIATION ONCOLOGY, 8(4), E199–E207. -
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer
Chin, A. L., Kumar, K. A., Guo, H. H., Maxim, P. G., Wakelee, H., Neal, J. W., … Gensheimer, M. F. (2018). Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer. CLINICAL LUNG CANCER, 19(5), E581–E588. -
Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases
Koenig, J. L., Shi, S., Sborov, K., Gensheimer, M. F., Le, G., Nagpal, S., … Pollom, E. L. (2019). Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases. WORLD NEUROSURGERY, 126, E1399–E1411. -
Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data
Gensheimer, M. F., Henry, A. S., Wood, D. J., Hastie, T. J., Aggarwal, S., Dudley, S. A., … Chang, D. T. (2019). Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 111(6), 568–74. -
Radiographic Extranodal Extension in Human Papillomavirus-Associated Oropharyngeal Carcinoma: Can it Help Tailor Treatment?
Gensheimer, M. F., & Le, Q.-T. (2019). Radiographic Extranodal Extension in Human Papillomavirus-Associated Oropharyngeal Carcinoma: Can it Help Tailor Treatment? International Journal of Radiation Oncology, Biology, Physics, 104(5), 1028–29. -
Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.
Moding, E. J., Liang, R., Lartey, F. M., Maxim, P. G., Sung, A., Diehn, M., … Gensheimer, M. F. (2019). Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors. Clinical Lung Cancer. -
Tumor Subregion Evolution-based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer.
Wu, J., Gensheimer, M., Zhang, N., Guo, M., Liang, R., Zhang, C., … Li, R. (2019). Tumor Subregion Evolution-based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. -
Predicting Survival for Patients with Metastatic Disease.
Benson, K. R., Aggarwal, S., Carter, J. N., von Eyben, R., Pradhan, P., Prionas, N. D., … Chang, D. T. (2019). Predicting Survival for Patients with Metastatic Disease. International Journal of Radiation Oncology, Biology, Physics. -
A radiation oncology-specific automated trigger indicator tool for high-risk near-miss safety events.
Hartvigson, P. E., Gensheimer, M. F., Spady, P. K., Evans, K. T., & Ford, E. C. (2019). A radiation oncology-specific automated trigger indicator tool for high-risk near-miss safety events. Practical Radiation Oncology. -
Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
Jin, M. C., Harris, J. P., Sabolch, A. N., Gensheimer, M., Le, Q.-T., Beadle, B. M., & Pollom, E. L. (2019). Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma. The Laryngoscope. -
Increases in Serial Pretreatment F-18-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
Prionas, N. D., von Eyben, R., Yi, E., Aggarwal, S., Shaffer, J., Bazan, J., … Loo, B. W. (2019). Increases in Serial Pretreatment F-18-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. ADVANCES IN RADIATION ONCOLOGY, 4(2), 429–37. -
Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume.
Binkley, M. S., Koenig, J. L., Kashyap, M., Xiang, M., Liu, Y., Sodji, Q., … Gensheimer, M. F. (2020). Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume. Radiation Oncology (London, England), 15(1), 114. -
Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology.
Gensheimer, M. F., Yom, S. S., Soto, N., Dignam, J. J., Le, Q.-T., Machtay, M., & Curran, W. J. (2020). Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology. International Journal of Radiation Oncology, Biology, Physics, 108(2), 483–85. -
A scalable discrete-time survival model for neural networks
Gensheimer, M. F., & Narasimhan, B. (2019). A scalable discrete-time survival model for neural networks. PEERJ, 7. -
Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice?
Gensheimer, M. F., & Le, Q.-T. (2018). Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice? ORAL ONCOLOGY, 86, 19–24. -
Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis
Berry, M. F., Canchola, A. J., Gensheimer, M. F., Gomez, S. L., & Cheng, I. (2018). Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis. CLINICAL LUNG CANCER, 19(5), E745–E758. -
Differentiation of overall survival by breast cancer tumor subtype following stereotactic radiosurgery for brain metastasis.
Cho, E., Rubinstein, L., Redman, M. W., Rockhill, J., Halasz, L. M., Gensheimer, M., … Gadi, V. K. (2014). Differentiation of overall survival by breast cancer tumor subtype following stereotactic radiosurgery for brain metastasis. JOURNAL OF CLINICAL ONCOLOGY, 32(15). -
Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
Zhang, N., Liang, R., Gensheimer, M. F., Guo, M., Zhu, H., Yu, J., … Wu, J. (2020). Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer. Theranostics, 10(25), 11707–18. -
Automated model versus treating physician for predicting survival time of patients with metastatic cancer.
Gensheimer, M. F., Aggarwal, S., Benson, K. R., Carter, J. N., Henry, A. S., Wood, D. J., … Chang, D. T. (2020). Automated model versus treating physician for predicting survival time of patients with metastatic cancer. Journal of the American Medical Informatics Association : JAMIA. -
Treatment Breaks During Definitive Head/Neck Radiotherapy: Survival Impact and Predisposing Factors
Xiang, M., Gensheimer, M., Pollom, E., Holsinger, F. C., Colevas, A. D., Quynh-Thu Le, & Beadle, B. (2020). Treatment Breaks During Definitive Head/Neck Radiotherapy: Survival Impact and Predisposing Factors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC. -
Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.
Xiang, M., Gensheimer, M. F., Pollom, E. L., Holsinger, F. C., Colevas, A. D., Le, Q.-T. T., & Beadle, B. M. (2020). Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology. -
Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma.
Xiang, M., Holsinger, F. C., Gensheimer, M. F., Divi, V., Pollom, E. L., Colevas, A. D., … Beadle, B. M. (2021). Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma. American Journal of Clinical Oncology, Publish Ahead of Print. -
Natural Language Processing to Identify Cancer Treatments With Electronic Medical Records.
Zeng, J., Banerjee, I., Henry, A. S., Wood, D. J., Shachter, R. D., Gensheimer, M. F., & Rubin, D. L. (2021). Natural Language Processing to Identify Cancer Treatments With Electronic Medical Records. JCO Clinical Cancer Informatics, 5, 379–93. -
Cancer Treatment Classification with Electronic Medical Health Records
Zeng, J., Banerjee, I., Gensheimer, M., & Rubin, D. (2020). Cancer Treatment Classification with Electronic Medical Health Records. THIRTY-FOURTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, THE THIRTY-SECOND INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE AND THE TENTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE. ASSOC ADVANCEMENT ARTIFICIAL INTELLIGENCE. -
Radiological tumour classification across imaging modality and histology
Wu, J., Li, C., Gensheimer, M., Padda, S., Kato, F., Shirato, H., … Li, R. (2021). Radiological tumour classification across imaging modality and histology. NATURE MACHINE INTELLIGENCE. -
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.
Benson, K. R., Sandhu, N., Zhang, C., Ko, R., Toesca, D. A., Lee, P. E., … Chang, D. T. (2021). Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy. American Journal of Clinical Oncology. -
Radiological tumor classification across imaging modality and histology.
Wu, J., Li, C., Gensheimer, M., Padda, S., Kato, F., Shirato, H., … Li, R. (2021). Radiological tumor classification across imaging modality and histology. Nature Machine Intelligence, 3, 787–798. -
Human-level comparable control volume mapping with a deep unsupervised-learning model for image-guided radiation therapy.
Liang, X., Bassenne, M., Hristov, D. H., Islam, M. T., Zhao, W., Jia, M., … Xing, L. (1800). Human-level comparable control volume mapping with a deep unsupervised-learning model for image-guided radiation therapy. Computers in Biology and Medicine, 141, 105139. -
Acute and Late Esophageal Toxicity Following Stereotactic Ablative Radiotherapy to Thoracic Tumors near or Abutting the Esophagus.
Sodji, Q. H., Ko, R., von Eyben, R., Owen, S. G., Capaldi, D. P., Bush, K., … Loo, B. W. (1800). Acute and Late Esophageal Toxicity Following Stereotactic Ablative Radiotherapy to Thoracic Tumors near or Abutting the Esophagus. International Journal of Radiation Oncology, Biology, Physics. -
Uncovering interpretable potential confounders in electronic medical records.
Zeng, J., Gensheimer, M. F., Rubin, D. L., Athey, S., & Shachter, R. D. (2022). Uncovering interpretable potential confounders in electronic medical records. Nature Communications, 13(1), 1014. -
De-escalating elective nodal irradiation for nasopharyngeal carcinoma.
Miller, J. A., Beadle, B. M., Gensheimer, M. F., & Le, Q.-T. (2022). De-escalating elective nodal irradiation for nasopharyngeal carcinoma. The Lancet. Oncology. -
IMRT and SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System.
Pham, D., Simiele, E., Breitkreutz, D., Capaldi, D., Han, B., Surucu, M., … Kovalchuk, N. (2022). IMRT and SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System. Technology in Cancer Research & Treatment, 21, 15330338221100231. -
Accuracy of Electronic Medical Record Follow-Up Data for Estimating the Survival Time of Patients With Cancer.
Gensheimer, M. F., Narasimhan, B., Henry, A. S., Wood, D. J., & Rubin, D. L. (2022). Accuracy of Electronic Medical Record Follow-Up Data for Estimating the Survival Time of Patients With Cancer. JCO Clinical Cancer Informatics, 6, e2200019. -
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Miller, J. A., Moradi, F., Sundaram, V., Liang, R., Zhang, C., Nguyen, N. K., … Gensheimer, M. F. (2022). Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma. Head & Neck. -
Dosimetric Predictors of Local Control after Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors: A Secondary Analysis of a Phase II Prospective Trial of Individualized SABR (iSABR)
Wu, Y. F., Lau, B., Fu, J., Skinner, L., Gensheimer, M., Gee, H., … Vitzthum, L. (2022). Dosimetric Predictors of Local Control after Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors: A Secondary Analysis of a Phase II Prospective Trial of Individualized SABR (iSABR). AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS. -
Considerations in the reliability and fairness audits of predictive models for advance care planning
Lu, J., Sattler, A., Wang, S., Khaki, A. R., Callahan, A., Fleming, S., … Shah, N. (2022). Considerations in the reliability and fairness audits of predictive models for advance care planning. Frontiers in Digital Health. -
Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504.
Gillison, M. L., Ferris, R. L., Harris, J., Colevas, A. D., Mell, L. K., Kong, C., … Le, Q. T. (2022). Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504. International Journal of Radiation Oncology, Biology, Physics. -
Use of systemic cancer treatments based on a validated survival prediction model in metastatic cancer.
Roy, M., Gensheimer, M. F., Chang, D. T., Singhal, S., & Khaki, A. R. (2022). Use of systemic cancer treatments based on a validated survival prediction model in metastatic cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer.
Gensheimer, M. F., Gupta, D., Patel, M. I., Fardeen, T., Hildebrand, R., Teuteberg, W., … Ramchandran, K. (2022). Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer. JCO Oncology Practice, OP2200128. -
Improving lung cancer screening rates among patients with head and neck cancer in a radiation oncology clinic
Soto, L., Nesbit, S., Ramsey, M., Gensheimer, M. F., Le, Q. T., Beadle, B. M., & Lui, N. S. (2022). Improving lung cancer screening rates among patients with head and neck cancer in a radiation oncology clinic. JOURNAL OF THORACIC DISEASE. -
Improving lung cancer screening rates among patients with head and neck cancer in a radiation oncology clinic.
Soto, L., Nesbit, S., Ramsey, M., Gensheimer, M. F., Le, Q. T., Beadle, B. M., & Lui, N. S. (2022). Improving lung cancer screening rates among patients with head and neck cancer in a radiation oncology clinic. Journal of Thoracic Disease, 14(12), 4633–4640. -
Mitigation of IMRT/SBRT treatment planning errors on the RefleXion X1 system using FMEA within Six Sigma framework
Simiele, E., Han, B., Skinner, L., Pham, D., Lewis, J., Gensheimer, M., … Kovalchuk, N. (2023). Mitigation of IMRT/SBRT treatment planning errors on the RefleXion X1 system using FMEA within Six Sigma framework. Advances in Radiation Oncology. -
Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery.
Wang, J.-Y. Y., Qu, V., Hui, C., Sandhu, N., Mendoza, M. G., Panjwani, N., … Pollom, E. L. (2023). Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery. Radiation Oncology (London, England), 18(1), 61. -
Pulmonary Hemorrhage in Patients Treated with Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents.
Lau, B., Wu, Y. F., No, H. J., Ko, R. B., Devine, M., Das, M. S., … Vitzthum, L. K. (2023). Pulmonary Hemorrhage in Patients Treated with Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. -
Patient-specific Auto-segmentation on Daily kVCT Images for Adaptive Radiotherapy.
Chen, Y., Gensheimer, M. F., Bagshaw, H. P., Butler, S., Yu, L., Zhou, Y., … Han, B. (2023). Patient-specific Auto-segmentation on Daily kVCT Images for Adaptive Radiotherapy. International Journal of Radiation Oncology, Biology, Physics. -
Unilateral diaphragmatic paralysis after stereotactic ablative radiotherapy to a lung tumor abutting the course of the phrenic nerve.
Eke, I., Guo, H. H., Loo, J. B., Sung, A. W., Diehn, M., Vitzthum, L., … Gensheimer, M. F. (2023). Unilateral diaphragmatic paralysis after stereotactic ablative radiotherapy to a lung tumor abutting the course of the phrenic nerve. Practical Radiation Oncology. -
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Saad, M. B., Hong, L., Aminu, M., Vokes, N. I., Chen, P., Salehjahromi, M., … Wu, J. (2023). Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. The Lancet. Digital Health. -
Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer.
Rahimy, E., Gensheimer, M. F., Beadle, B., & Le, Q.-T. T. (2023). Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer. Seminars in Radiation Oncology, 33(3), 336–347. -
Adaptive Region-Specific Loss for Improved Medical Image Segmentation.
Chen, Y., Yu, L., Wang, J.-Y., Panjwani, N., Obeid, J.-P., Liu, W., … Xing, L. (2023). Adaptive Region-Specific Loss for Improved Medical Image Segmentation. IEEE Transactions on Pattern Analysis and Machine Intelligence, PP. -
Study of Patient and Physician Attitudes Toward Automated Prognostic Models for Patients With Metastatic Cancer.
Hildebrand, R. D., Chang, D. T., Ewongwoo, A. N., Ramchandran, K. J., & Gensheimer, M. F. (2023). Study of Patient and Physician Attitudes Toward Automated Prognostic Models for Patients With Metastatic Cancer. JCO Clinical Cancer Informatics, 7, e2300023. -
Potential Biases in a Population-based Study of Surveillance Imaging for Head and Neck Cancer.
Gensheimer, M. F. (2023). Potential Biases in a Population-based Study of Surveillance Imaging for Head and Neck Cancer. Radiology, 308(2), e230286. -
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial.
Gensheimer, M. F., Gee, H., Shirato, H., Taguchi, H., Snyder, J. M., Chin, A. L., … Diehn, M. (2023). Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial. JAMA Oncology. -
Lessons Learned from a Multi-Site, Team-Based Serious Illness Care Program Implementation at an Academic Medical Center.
Seevaratnam, B., Wang, S., Fong, R., Hui, F., Callahan, A., Chobot, S., … Teuteberg, W. (2023). Lessons Learned from a Multi-Site, Team-Based Serious Illness Care Program Implementation at an Academic Medical Center. Journal of Palliative Medicine. -
Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation Oncology.
Bitterman, D. S., Gensheimer, M. F., Jaffray, D., Pryma, D. A., Jiang, S. B., Morin, O., … Kibbe, W. (2023). Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation Oncology. JCO Clinical Cancer Informatics, 7, e2300136. -
BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiotherapy.
Vitzthum, L. K., Surucu, M., Gensheimer, M. F., Kovalchuk, N., Han, B., Pham, D., … Garant, A. (2023). BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiotherapy. International Journal of Radiation Oncology, Biology, Physics. -
First-Year Experience of Stereotactic Body Radiation Therapy/Intensity Modulated Radiation Therapy Treatment Using a Novel Biology-Guided Radiation Therapy Machine.
Shi, M., Simiele, E., Han, B., Pham, D., Palomares, P., Aguirre, M., … Kovalchuk, N. (2024). First-Year Experience of Stereotactic Body Radiation Therapy/Intensity Modulated Radiation Therapy Treatment Using a Novel Biology-Guided Radiation Therapy Machine. Advances in Radiation Oncology, 9(1), 101300. -
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Gharzai, L. A., Morris, E., Suresh, K., Nguyen-Tân, P. F., Rosenthal, D. I., Gillison, M. L., … Schipper, M. J. (2024). Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis. The Lancet. Oncology, 25(3), 366–375. -
Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial.
Lau, B., Wu, Y. F., Cui, S., Fu, J., Jackson, S., Pham, D., … Vitzthum, L. K. (2024). Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 110317. -
Commissioning of a novel PET-Linac for biology-guided radiotherapy (BgRT).
Surucu, M., Ashraf, M. R., Romero, I. O., Zalavari, L. T., Pham, D., Vitzthum, L. K., … Han, B. (2024). Commissioning of a novel PET-Linac for biology-guided radiotherapy (BgRT). Medical Physics. -
Large Language Model-Augmented Auto-Delineation of Treatment Target Volume in Radiation Therapy.
Rajendran, P., Yang, Y., Niedermayr, T. R., Gensheimer, M., Beadle, B., Le, Q.-T. T., … Dai, X. (2024). Large Language Model-Augmented Auto-Delineation of Treatment Target Volume in Radiation Therapy. ArXiv. -
Automated patient selection and care coaches to increase advance care planning for cancer patients.
Gensheimer, M. F., Teuteberg, W., Patel, M. I., Gupta, D., Noroozi, M., Ling, X., … Ramchandran, K. (2024). Automated patient selection and care coaches to increase advance care planning for cancer patients. Journal of the National Cancer Institute. -
A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer.
Gensheimer, M. F., Kotha, N. V., Vitzthum, L. K., Chin, A. L., Jackson, S., 't Erve, I. van, … Neal, J. W. (2024). A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur Palo Alto, CA
Palo Alto, CA
CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereRadiation Oncology at Blake Wilbur Building Palo Alto, CA
Palo Alto, CA
Radiation Oncology at Blake Wilbur Building
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereHead and Neck Cancer Program at 875 Blake Wilbur Palo Alto, CA
Palo Alto, CA
Head and Neck Cancer Program at 875 Blake Wilbur
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(101 reviews)
Wonderful doctor and I’m grateful that he was my radiation doctor for my cancer .
Dr Genshiemer listens to my questions very well. I appreciate that very much.
Excellent by any standard.
The visit was very good!
Did a great job explaining situation.
Fine Dr.
He is an excellent doctor. I am grateful that he explains clearly, listens attentively and seems to be genuinely interested in the care of his patients.
I find it very easy to talk with him! I am very impressed with him and, for that matter, all the doctors, nurses and technicians that I have met during my treatments. Thanks, one and all!!!
Very polite and kind
Dr. Gensheimer is easy to understand and is very positive. He explained any future needs and what he will be watching for in new scans and tests. I like talking with him.
Dr. Gensheimer seems very competent and explains his work very well. I appreciate his concern and efficiency in dealing with my health issues. It was helpful that he told me I was doing well when going through the procedures for the SBRT. Because it seemed I had to lie a certain way, it was gratifying to have him mention that my efforts had been good. As part of the process, it was wonderful to be able to ring the bell afterwards with my husband and daughter in attendance. That gesture had such a powerful meaning for me that reading the poem and ringing the bell brought on tears. Thank you for that!
During my recent post lung surgery appointment followup another doctor and staff nurse participated. All knew my case well and had an earlier internal discussion discussion. Excellent teamwork to address my concerns.
This was a very productive consultation. All questions addressed and was very helpful in making decisions for future treatment.
no problems, visit well done
Enjoyed the visit.
Excellent doctor
You always go away with a feeling that people care about you.
Excellent doctor - as far as you can see that in the video. Helpful in making other doctors appointment.
I appreciate him
Warm, patient, kind, helpful staff at all levels - from gardeners to doctors.
Good Doctor,.
More optimistic prognosis would be my only request. We should team up and make me better.
Thank you for the informative visit
Dr. Gensheimer is top notch in every way. He continues to exceed our expectations with every visit!
Dr. Gensheimer was very helpful in answering our questions as a family to process our decision in continuing treatment.
It is very good Doctor team
Excellent in knowledge and communication.
Dr. Gensheimer is an excellent doctor/radiologist. He explains medical terms so I can understand them. He is very caring and easy to talk to.
I feel comfortable with him and I have a lot of confidence in him.
We thought he was very thorough and friendly.
Doctor Gensheimer is always optimistic and positive and informative. Great doctor.
Thorough information presented in professional manner!
Compassionate and caring Doctor. Covers medical data from tests taken and proposed treatment in understandable terms and explained risks involved.
I appreciate his approach.
outstanding medical professional with a excellent interpersonal skills
He was very nice and answered all my questions and concerns, very through.
Dr. Gensheimer is always thoughtful about getting my questions answered as completely as possible.
He was excellent today.
I have never had such good service anywhere as I have had at Stanford hospital. Everyone who works here goes out of their way to help you.
The staff and doctors were very informative professional and kind
Good service as always
Was nice. & warm
Dr Genshiemer and staff are always kind, considerate and helpful. He is always thorough in his answers.
Always top notch care from every staff member!
Thank you Doc for all you have done for me
You people are great
I think he is the best! Couldn’t ask for a better Dr.
Both the cancer center and cardiac facilities are excellent. Both treat me with kindness and professionalism.
Explains things clearly
Care was good, getting around hospitals was confusing at beast
Dr. Gensheimer is very easy to talk to. He made me feel less anxious about the upcoming radiation treatment. He knows how to explain things so that I understand.
Seemed like a good and knowledgeable guy
Very patient and helpfully.
I am pleased with how the visit went.
Very informative and thank you for the advice on my care
Comforting to talk to Dr. Gensheimer. Very good listener. Very professional.
Very positive and informational
He was clear, warm and informative.
He is very thorough and has explained my situation and options so I clearly understand them. He is genuine and very caring. I feel very fortunate to have him as one of my doctors.
Good visit. Thanks.
Dr. Genshimer and RN Wong are competent, listen well and customer focused!
had wonderful care
Dr was caring and reassured me that my care was on track. He also said he would follow up on me in the future. That means a lot.
Dr. Gensheimer is the most kindest, caring, compassionate doctor I know. He is the best!
Always
I couldn’t have a better MD I think the Gunslinger is GREAT!!!
I recommend Stanford often.
He's doing a great job.
Dr. Gensheimer is very knowledgeable, friendly and easy to talk with. Even though he will not be treating me he would like to stay in the loop of my care with the other Stanford doctors. He also said if I had any questions in the future or wanted another opinion on something he would welcome my message to him. This was very much appreciated.
Excellent communicator and answered all of my questions.
Dr. Gensheimer is very personable, professional, and thorough; he provided an excellent treatment overview!
Dr. Gensheimer is very professional and has a kind demeanor. He is patient and always takes the time to answer my questions and respond to my concerns. I am very impressed with his attention to details. He would frequently check on my radiation treatment set-up, and provide positive input and suggestions to the Radiation Therapists. It truly felt like a team effort.
Dr. Michael Gensheimer is a saint! He saved my life and cared for me like a family member. He is an excellent doctor and an amazing human being! He is kind, caring, efficient, detailed, polite, patient, precise, friendly and a true professional. Wish we could clone him! He is a great example to emulate!
Dr. Gensheimer always explains everything clearly and in a caring manner. He is surely a superb doctor and I feel blessed to be in his care.
The dr. really spent time answering questions & my concerns.
Dr. Gensheimer followed up with dad's CT scan results and immediately recommended an additional PEt scan to double check. He returned my call within a few hours - on a Friday!
Dr. Gensheimer is a super doctor with wonderful bedside manner & is always up beat, friendly & kind - He has such incredible knowledge but doesn't come off as condescending or cocky - A fabulous doctor! I'm grateful to be in his care.
Doctors & nurses were all friendly & providing us the highest level of medical care. Thanks a lot for that.
Dr. Gensheimer is great.
Always A+!
Good experience.
Always very friendly but to the point.
I appreciate that I have never felt rushed at any appt. I have had at Stanford. Doctors and staff give me all the time I need - Always. Thank you!
EXCELLENT experience.
Very patient centered & thorough!
Wanting to thank all the good treatment and excellent medical attention from all the doctors, surgeons, nurses etc.
1st visit with this doctor after Dr. Hara left, Dr. Gensheimer and his assistant Dr. Jacob Miller were excellent in providing lots of answers, showing concern and telling follow up care plans.
Dr. Gensheimer is absolutely the BEST MD I've ever worked with - off the chart. To whatever extent my cancer issues may continue in the future, I hope to rely on him absolutely and always.
Exceptional person and doctor.
Best post surgical visit yet! Awesome!
Great experience.
He was very professional and made sure that I had the good and bad about my up coming procedure.
I would like to extend my appreciation to Dr. Michale, it was my first visit to his clinic and I appreciate the time and information he gave me. not only that yesterday he called me and informed me about the result and told me that his team will contact me to schedule the treatment plan. I appreciate the courtesy from the doctor when he called to let me know about the result and the plan.
I was made at ease - explanations re: problem excellent.
Dr. Gensheimer and Gail O'Hanlon RN are superb.
Love Dr. Gensheimer!
Great experience as usual! We are glad Dr. Gensheimer is back.
Dr. Gensheimer to much time out of office and on vacation during my time of appointments; I understand now because he have moved from Stanford Health Care. Thanks Dr. G.
Dr. Gensheimer, though young, is an excellent radiation oncologist, in my opinion. I have 8 yrs. of dealing with drs., and he is one of the best. Also RN Gillian McFarlane is one of the best nurses I have dealt with. Stanford Medical has the best staff I have experienced.
Dr. Genshelmer & staff are awesome!!
Dr. Gensheimer told me about all my cancer very very in full.
Very professional care providers & staff.
Caring attitude by all.
The dr. has always been wonderful in that he never made me feel my appointment was rushed.
Exceptional in every regard - the optimal of professionalism.
View More
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records